Refanezumab Uses, Dosage, Side Effects and more
Refanezumab is under investigation in clinical trial NCT00833989 (Safety Escalating Repeat IV, in Stroke Patients).
| Attribute | Details |
|---|---|
| Trade Name | Refanezumab |
| Generic | Refanezumab |
| Refanezumab Other Names | Refanezumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
